High rates of pulmonary artery occlusions in COVID‐19. A meta‐analysis

Background COVID‐19 patients are considered at high risk of venous thromboembolism (VTE). The real nature of pulmonary artery occlusions (PAO) in COVID‐19 has been questioned, suggesting that it is caused also by in situ thrombi, rather than only by emboli (PE) from peripheral thrombi. Methods We se...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	European journal of clinical investigation Ročník 51; číslo 1; s. e13433 - n/a
Hlavní autoři:	Birocchi, Simone, Manzoni, Marco, Podda, Gian Marco, Casazza, Giovanni, Cattaneo, Marco
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	England Blackwell Publishing Ltd 01.01.2021 John Wiley and Sons Inc
Témata:	Anticoagulants - therapeutic use Case-Control Studies COVID-19 COVID-19 - epidemiology embolism and thrombosis Heparin Heparin - therapeutic use Heparin, Low-Molecular-Weight - therapeutic use Humans low‐molecular‐weight heparin Meta-analysis Original Original Papers Prevalence Pulmonary arteries Pulmonary Artery Pulmonary Embolism - epidemiology Pulmonary Embolism - prevention & control SARS coronavirus SARS-CoV-2 Thromboembolism Thrombosis Thrombosis - epidemiology Thrombosis - prevention & control Venous Thrombosis - epidemiology Venous Thrombosis - prevention & control COVID-19 low-molecular-weight heparin embolism and thrombosis SARS coronavirus
ISSN:	0014-2972, 1365-2362, 1365-2362
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!